Bayer AG (BAYRY) reports modest sales growth and debt reduction amid financial headwinds and strategic challenges.

Wolfgang will then provide an overview of our financial performance in 2024 along with the outlook for 2025. We will then hear from our Divisional Heads who will delve into last year's performance of ...

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an ...

Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...

Cameron Carter-Vickers has revealed that Daizen Maeda has caught the eye of Bayern Munich’s superstars. Celtic’s Japanese forward took his goal tally for the season to 25 on Tuesday with a ...

Feb. 21—In 1900, German drug company Bayer filed a patent in the U.S. for a tiny white pill that would be the foundation of future success: Aspirin. The company also filed a trademark for the name.

Its economy hadn’t just withstood the ascendance of China; it was thriving in its wake. Its balanced public finances stood out in a world of huge government debt. And while British and U.S ...